By Kiran Mazumdar-Shaw and Dr. Murali Panchapagesa Muthuswamy The global economy is on the cusp of a “biological industrial revolution”. Synthetic biology (SynBio)—the design and construction of new biological parts, devices, and systems—is no longer a niche academic pursuit but a disruptive force poised to rewire how we heal, feed, and fuel the world. For … Continue reading Engineering the Future: India’s Trillion-Dollar Synthetic Biology Opportunity
Kiran Mazumdar-Shaw Writes: Biotechnology is Key to Tech Transformation
Biotechnology is emerging as one of the most transformative fields of our time, offering solutions to critical challenges in health, agriculture and sustainability. For India, the journey toward technology sovereignty in this sector represents not only a vision for self-reliance but also an opportunity to establish itself as a global biotech powerhouse. Economic and Strategic … Continue reading Kiran Mazumdar-Shaw Writes: Biotechnology is Key to Tech Transformation
Year-End Reflections: Driving India’s Bio-Revolution
- By Kiran Mazumdar-Shaw India's biopharmaceutical sector achieved significant milestones in 2024, reinforcing its position as a global leader in affordable healthcare solutions. The industry's focus on biologics, vaccines, medical devices, and diagnostics has made a difference to the lives of nearly every Indian and millions more globally. The biopharma sector has emerged as a … Continue reading Year-End Reflections: Driving India’s Bio-Revolution
Biology – The New Frontier
Global Bio-India 2024 Inaugural Speech by Kiran Mazumdar-Shaw, Chairperson, Biocon and Biocon Biologics Namaskar! It is an honour to address you today at Global Bio India at a time when Biology is recognised as the most exciting and transformative fields of our time. More than ever before, biology has become the new frontier, a realm … Continue reading Biology – The New Frontier
Budget Needs to Spur Research and Innovation-Led Economic Growth
Finance Minister Nirmala Sitharaman is all set to present the Budget for FY24-25 on February 1, 2024. As the general elections are expected in a few months, this Budget will be an interim one. The economic context in which this Budget will be presented is encouraging. Despite global volatility between 2020 and 2023, India’s GDP grew … Continue reading Budget Needs to Spur Research and Innovation-Led Economic Growth
Year-End Reflection: India’s Biotech and Pharma Sectors Can Catalyse Transformational Growth
As we bid farewell to 2023, it is opportune to reflect on the pivotal juncture that India finds itself in—a moment that holds the promise of transformative growth and innovation in 2024 and beyond. Unleash the Potential of Biotechnology Over the last several years, biotechnology in India has transformed from a nascent sector to a … Continue reading Year-End Reflection: India’s Biotech and Pharma Sectors Can Catalyse Transformational Growth
$150-Billion Bioeconomy by 2025: Policy Prescriptions for Building a Vibrant Biotech Sector
By Kiran Mazumdar-Shaw In the face of the biggest health calamity faced by humanity in a century, India’s Bioeconomy grew over 12% to reach $70.2 billion in 2020. The biotech industry braved the challenges of Covid-19 to develop innovative solutions such as diagnostics, therapies and vaccines at speed and scale to save countless lives. India … Continue reading $150-Billion Bioeconomy by 2025: Policy Prescriptions for Building a Vibrant Biotech Sector
From Brewing to Biologics: Kiran Mazumdar-Shaw in conversation with Catherine Jewell, Communications Division, WIPO
Kiran Mazumdar-Shaw shares with Catherine Jewell, her story of innovation and entrepreneurship; Her journey from brewing to creating Biocon, Asia's leading Biopharmaceutical Company.